Next Generation CAR & T Cell Therapies
June 18, 2019 ‐ June 20, 2019 in San Francisco, CA (USA)
The Next Generation CAR & T Cell Therapies Conference will be held from June 18 - 20, 2019 in San Francisco, California.
Julien Valton, Ph.D., Innovation Team Leader at Cellectis, will participate in the conference with a presentation on "Repurposing Endogenous Immune Pathways to Tailor and Control Chimeric Antigen Receptor T-cell Functionality" on June 18 at 9:15 AM PT.
David Sourdive, Ph.D., Executive Vice President, Technical Operations at Cellectis, to also take part in this event with a case study presentation titled, "UCART: Allogeneic Immune-Oncology" on June 19 at 8:15 AM PT.